This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Theilacker, C.
Right arrow Articles by Pier, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theilacker, C.
Right arrow Articles by Pier, G. B.

 Previous Article  |  Next Article 

Infection and Immunity, July 2003, p. 3875-3884, Vol. 71, No. 7
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.7.3875-3884.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Construction and Characterization of a Pseudomonas aeruginosa Mucoid Exopolysaccharide-Alginate Conjugate Vaccine

Christian Theilacker, Fadie T. Coleman, Simone Mueschenborn, Nicolas Llosa, Martha Grout, and Gerald B. Pier*

Channing Laboratory, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115-5804

Received 18 November 2002/ Returned for modification 12 February 2003/ Accepted 26 March 2003

Deterioration of lung function in patients with cystic fibrosis (CF) is closely associated with chronic pulmonary infection with mucoid Pseudomonas aeruginosa. The mucoid exopolysaccharide (MEP) from P. aeruginosa has been shown to induce opsonic antibodies in mice that are protective against this chronic infection. MEP-specific opsonic antibodies are also commonly found in the sera of older CF patients lacking detectable P. aeruginosa infection. When used in a human vaccine trial, however, MEP only minimally induced opsonic antibodies. To evaluate whether conjugation of MEP to a carrier protein could improve its immunogenicity, we bound thiolated MEP to keyhole limpet hemocyanin (KLH) by using succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) as a linker. In contrast to the native MEP polymer, the MEP-KLH conjugate vaccine induced high titers of MEP-specific immunoglobulin G (IgG) in C3H-HeN mice and in a rabbit. Sera from mice immunized with MEP-KLH conjugate, but not from animals immunized with comparable doses of native MEP, demonstrated opsonic killing activity. Vaccination with MEP-KLH conjugate induced opsonic antibodies broadly cross-reactive to heterologous mucoid strains of P. aeruginosa. Preexisting nonopsonic antibodies to MEP are found in normal human sera, including young CF patients, and their presence impedes the induction of opsonic antibodies. Induction of nonopsonic antibodies by either intraperitoneal injection of MEP or injection or feeding of the cross-reactive antigen, seaweed alginate, reduced the level of overall IgG elicited by follow-up immunization with the MEP-KLH conjugate. However, the opsonic activity was lower only in the sera of MEP-KLH conjugate-immunized mice with preexisting antibodies induced by MEP but not with antibodies induced by seaweed alginate. Immunization with MEP-KLH elicited a significant proportion of antibodies specific to epitopes involving O-acetate residues, and this subpopulation of antibodies mediated opsonic killing of mucoid P. aeruginosa in vitro. These results indicate that conjugation of MEP to KLH significantly enhances its immunogenicity and the elicitation of opsonic antibodies in mice and rabbits, that the conjugate induces opsonic antibodies in the presence of preexisting nonopsonic antibodies, and that opsonic antibodies to MEP are directed at epitopes that include acetate residues on the uronic acid polymer.

* Corresponding author. Mailing address: Channing Laboratory, Department of Medicine, Harvard Medical School, Boston, MA 02115-5804. Phone: (617) 525-2269. Fax: (617) 525-2510. E-mail: gpier{at}channing.harvard.edu.

Editor: V. J. DiRita

Infection and Immunity, July 2003, p. 3875-3884, Vol. 71, No. 7
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.7.3875-3884.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Zaidi, T., Pier, G. B. (2008). Prophylactic and Therapeutic Efficacy of a Fully Human Immunoglobulin G1 Monoclonal Antibody to Pseudomonas aeruginosa Alginate in Murine Keratitis Infection. Infect. Immun. 76: 4720-4725 [Abstract] [Full Text]  
  • Theilacker, C., Kaczynski, Z., Kropec, A., Fabretti, F., Sange, T., Holst, O., Huebner, J. (2006). Opsonic Antibodies to Enterococcus faecalis Strain 12030 Are Directed against Lipoteichoic Acid.. Infect. Immun. 74: 5703-5712 [Abstract] [Full Text]  
  • Kashef, N., Behzadian-Nejad, Q., Najar-Peerayeh, S., Mousavi-Hosseini, K., Moazzeni, M., Djavid, G. E. (2006). Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate.. J Med Microbiol 55: 1441-1446 [Abstract] [Full Text]  
  • Mugabe, C., Halwani, M., Azghani, A. O., Lafrenie, R. M., Omri, A. (2006). Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa.. Antimicrob. Agents Chemother. 50: 2016-2022 [Abstract] [Full Text]  
  • Marcato, P., Griener, T. P., Mulvey, G. L., Armstrong, G. D. (2005). Recombinant Shiga Toxin B-Subunit-Keyhole Limpet Hemocyanin Conjugate Vaccine Protects Mice from Shigatoxemia. Infect. Immun. 73: 6523-6529 [Abstract] [Full Text]  
  • DiGiandomenico, A., Rao, J., Goldberg, J. B. (2004). Oral Vaccination of BALB/c Mice with Salmonella enterica Serovar Typhimurium Expressing Pseudomonas aeruginosa O Antigen Promotes Increased Survival in an Acute Fatal Pneumonia Model. Infect. Immun. 72: 7012-7021 [Abstract] [Full Text]  
  • Pier, G. B., Boyer, D., Preston, M., Coleman, F. T., Llosa, N., Mueschenborn-Koglin, S., Theilacker, C., Goldenberg, H., Uchin, J., Priebe, G. P., Grout, M., Posner, M., Cavacini, L. (2004). Human Monoclonal Antibodies to Pseudomonas aeruginosa Alginate That Protect against Infection by Both Mucoid and Nonmucoid Strains. J. Immunol. 173: 5671-5678 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»